Laboratory acute flaccid paralysis surveillance in Malaysia: A decade of commitment to the who global polio eradication initiative

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 35, Issue 2, 2004, Pages 421-424

  Saraswathy, T S ^a   Khairullah, N S ^a   Sinniah, M ^b   Fauziah, M K ^a   Apandi, M Y ^b   Shamsuddin, M ^a  

^a INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^b HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM;

ACUTE DISEASE; ARTICLE; AUSTRALIA; CELL CULTURE; CONTROLLED STUDY; COXSACKIE VIRUS B; ECHO VIRUS; ENTEROVIRUS; ENTEROVIRUS 71; FLACCID PARALYSIS; HEALTH SURVEY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALAYSIA; POLIOMYELITIS; POLIOMYELITIS VIRUS; SERODIAGNOSIS; STANDARDIZATION; VIROLOGY; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN; WILD TYPE; WORLD HEALTH ORGANIZATION;

EID: 4544306035     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Adas T. Farewell to polio in the Western Pacific. Bull. WHO 2000; 78: 1375.
2. CDC. Progress towards poliomyelitis eradication, 2000. MMWR 2001; 50: 320-2.
3. Evans DM, Dunn G, Minor PD, et al. Increased neurovirulence associated with a single nucleotide change in a non-coding region of the Sabin type 3 polio vaccine genome. Nature 1985; 314: 548-50.
4. Dietz V, Andrus JK, Olive J-M, Cochi SL, de Quadros CA. Epidemiology and clinical characteristics of acute flaccid paralysis associated with non-polio enteroviruses infection: the experience in the Americas. Bull WHO 1995; 73: 597-603.
5. WHO. Polio laboratory manual. Geneva: Department of Vaccines and Biologicals, World Health Organization, 2001.